Annals of the New York Academy of Sciences · 2004 · 20 citations · 5 references
Life SciencesImmunologyPharmacotherapyAutoimmunityClinical ImmunologyImmunotherapyDrug ToleranceImmune ToleranceImmune Tolerance InductionOral ToleranceUveal ImmunologyB-cell Responses In UveitisHla-b27 - Associated UveitisOcular Tolerance MechanismsOral Tolerance InductionOral Tolerance TherapyTolerance Induction Mechanisms
Oral tolerance induction with peptide B27PD had an ameliorating effect in uveitis patients, which was also observed in the five-year follow-up period. Repeated treatments with peptide B27PD were also effective. Side effects did not occur in this patient group, not even in patients receiving peptide for up to 42 weeks.
5
Human S-antigen determinant recognition in uveitis.
Marc D. de Smet, G Bitar, S Mainigi et al. · PubMed · 2001 · 82 citations
Stephan Thurau, Maria Diedrichs‐Möhring, Harald Fricke et al. · Immunology Letters · 1997 · 61 citations